Avalo Therapeutics Inc (AVTX)
11.00
+0.21
(+1.95%)
USD |
NASDAQ |
May 23, 16:00
11.00
0.00 (0.00%)
After-Hours: 16:14
Avalo Therapeutics Accounts Payable (Quarterly): 0.916M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.916M |
December 31, 2023 | 0.446M |
September 30, 2023 | 0.789M |
June 30, 2023 | 0.751M |
March 31, 2023 | 5.565M |
December 31, 2022 | 2.882M |
September 30, 2022 | 1.447M |
June 30, 2022 | 2.164M |
March 31, 2022 | 3.757M |
December 31, 2021 | 3.369M |
September 30, 2021 | 3.568M |
June 30, 2021 | 3.965M |
March 31, 2021 | 11.91M |
December 31, 2020 | 2.574M |
September 30, 2020 | 1.927M |
June 30, 2020 | 2.558M |
March 31, 2020 | 2.726M |
December 31, 2019 | 2.078M |
September 30, 2019 | 0.8265M |
Date | Value |
---|---|
June 30, 2019 | 1.446M |
March 31, 2019 | 1.250M |
December 31, 2018 | 1.446M |
September 30, 2018 | 1.536M |
June 30, 2018 | 2.940M |
March 31, 2018 | 3.166M |
December 31, 2017 | 1.299M |
September 30, 2017 | 0.3125M |
June 30, 2017 | 0.3273M |
March 31, 2017 | 0.5959M |
December 31, 2016 | 1.010M |
September 30, 2016 | 0.8092M |
June 30, 2016 | 0.7565M |
March 31, 2016 | 0.591M |
December 31, 2015 | 0.6781M |
September 30, 2015 | 1.952M |
June 30, 2015 | 1.246M |
March 31, 2015 | 0.722M |
December 31, 2014 | 0.9311M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.446M
Minimum
Dec 2023
11.91M
Maximum
Mar 2021
2.783M
Average
2.361M
Median
Accounts Payable (Quarterly) Benchmarks
Imunon Inc | 2.358M |
iBio Inc | 1.228M |
Kodiak Sciences Inc | 2.485M |
Petros Pharmaceuticals Inc | 2.137M |
Ocugen Inc | 1.731M |